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Background: Breast cancer is one of the most dreading types of cancer among women. Herbal medicine has
becoming a potential source of treatment for breast cancer. Herbal plant Dillenia suffruticosa (Griff) Martelli under
the family Dilleniaceae has been traditionally used to treat cancerous growth. In this study, the anticancer effect of
ethyl acetate extract of D. suffruticosa (EADs) was examined on human breast adenocarcinoma cell line MCF-7 and
the molecular pathway involved was elucidated.
Methods: EADs was obtained from the root of D. suffruticosa by using sequential solvent extraction. Cytotoxicity was
determined by using MTT assay, mode of cell death by cell cycle analysis and apoptosis induction by Annexin-FITC/PI
assay. Morphology changes in cells were observed under inverted light microscope. Involvement of selected genes in
the oxidative stress-mediated signaling pathway was explored using multiplex gene expression analysis.
Results: The treatment of EADs caused cytotoxicity to MCF-7 cells in a dose- and time-dependent manner at 24, 48
and 72 hours with IC50 of 76 ± 2.3, 58 ± 0.7 and 39 ± 3.6 μg/mL, respectively. The IC50 of tamoxifen-treated MCF-7 cells
was 8 ± 0.5 μg/mL. Induction of apoptosis by EADs was dose- and time- dependent. EADs induced non-phase specific
cell cycle arrest at different concentration and time point. The multiplex mRNA expression study indicated that
EADs-induced apoptosis was accompanied by upregulation of the expression of SOD1, SOD2, NF-κB, p53, p38 MAPK,
and catalase, but downregulation of Akt1.
Conclusion: It is suggested that EADs induced apoptosis in MCF-7 cells by modulating numerous genes which are
involved in oxidative stress pathway. Therefore, EADs has the potential to act as an effective intervention against breast
cancer cells.
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Breast cancer is the most typical cancer diagnosed among
women thus far [1]. The mortality rate of breast cancer
declines over the year and the latest five years data affirm
that breast cancer incidence rate is stable [2]. Death rate
in female patients reduces by 15.3% since year 1991 due* Correspondence: latifahsy@upm.edu.my
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reproduction in any medium, provided the orto amelioration in early detection and treatment [3].
Nevertheless, breast cancer cases are still accounting for
23% of total new cancer cases globally [4]. With advance
in molecular knowledge, more novel anti-cancer agents
with great selectivity and specificity ought to be developed
to overcome limitation of current treatments.
Deregulated cell proliferation and inhibition of cell death
evoke uncontrolled development of cancer [5]. Cancer cells
exhibit resistance to apoptosis or cell death in order to
survive and metastasize [6]. The common feature of cancer
progression, inclusive of breast cancer, is genetic alteration. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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anti-apoptotic genes that provides an insight to a target of
treatment [7]. The treatment strategy aims to destroy
cancer cells by activating their apoptotic signaling
pathways, ideally to induce selective apoptosis cell
death on cancer cells, and exert no harmful effects
on normal cells [8,9].
Apoptosis form of cell death is chosen to eliminate
cancer cells instead of other alternative mechanism because
it is a series of regulated cell events that perform cellular
suicide without triggering inflammatory response, and
neither harmful to neighboring cells. It differs from
necrosis that causes membrane rupture thus elicits inflam-
matory response [10]. Most importantly, apoptotic form
of cell death is occasionally altered in cancer cells.
The understanding of apoptosis unfolds a gate to tumor-
specific apoptosis therapy [11].
Reactive oxygen species (ROS) such as hydroxyl radical
(OH-), superoxide anions (O2
-), hydrogen peroxide (H2O2)
and peroxyl radicals (ROO-) are common products of
aerobic metabolism that can be useful or harmful to
biological system [12]. Low concentration of ROS
may facilitate signal transduction, enzyme activation
and other cellular functions, but high concentration
of ROS generates damage to DNA, protein and lipid
which can lead to cells transformation such as cancer
[13,14]. To offset the ROS detrimental effect, cells are
complement with antioxidant defense system transform-
ation that includes superoxide dismutases, catalase,
glutathione and others as protective mechanism [15].
In fact, ROS and antioxidants exist in balance under
normal circumstances. When the equilibrium between
ROS and anti-oxidants is disrupted, collective generation
of ROS is described as oxidative stress [16]. Evidence
showed that ROS not only function as regulator of subcel-
lular events but are also able to induce cell death through
apoptotic pathway [17]. Recently, many anticancer agents
such as 5-fluorouracil, tamoxifen and paclitaxel exploit
this channel to eliminate cancer cells by continually exert
cellular ROS to a threshold that can kill cancerous cells
effectively [14,18-20].
Plant has long history as a source of anticancer agents,
and gives prominent impact on modern drug development
process [21]. Over the last 20 years, exceeding 25% of drugs
are plant derived while another 25% are originated from
chemically modified natural products [22]. Plant-based
anticancer drugs such as etoposide (topoisomerase II
inhibitor) from epipodophyllotoxins, topotecan and
irinotecan (topoisomerase I inhibitor) from camptothecins,
vincristine and vinblastine (tubulin-binding agent) from
vinca alkaloids, induce apoptosis in chemotherapeutic
therapy against various types of cancer [23,24]. The
main target of action for those anti-cancer drugs may
be distinct, but eventually they lead to identical celldeath pathway, which is apoptosis [25,26]. Therefore, in
order to discover more plant-based anticancer agent,
various plant extracts were investigated for their
apoptosis-inducing ability. Interestingly, although plants
are frequently reported to possess antioxidant activity,
some of them are found to exert distinguish apoptosis
inducing ability through the induction of oxidative
stress [27-30].
Dillenia suffruticosa (Griff) Martelli (D. suffruticosa),
which belongs to family Dilleniaceae, is a plant native in
Peninsular Malaysia, Kalimantan, Sumatra and Singapore
[31,32]. The evergreen shrub can be found in secondary
forest and swampy ground. The fruit of the plant has the
ability to treat cancerous growth [33]. Other traditional
use of the plant is to relieve rheumatism [34]. Methanolic
extract of D. suffruticosa showed a broad spectrum of
antimicrobial activity against Bacillus cereus, Bacillius
subtilis, Candida albicans, and Pseudomonas aeruginosa
[35]. Water extract of D. suffruticosa also exhibited
inhibitory action against replication of dengue virus type 2
[36]. Armania et al. [37] reported that extract of D.
suffruticosa showed high antioxidant and cytotoxic
activities towards various cell lines including Hela,
MCF-7, MDA-MB-231, A549 and HT-29 cell lines. In
this study, root extract was selected for elaborated study.
As the previous study demonstrated that root extract of
the plant exhibited the most potent cytotoxic activity, in
comparison to fruit, leaf, and flower parts of the plant.
The aim of this study was to investigate the anticancer
effect of ethyl acetate of D. suffruticosa (EADs) in breast




Hexane, dichloromethane, ethyl acetate and dimethyl
sulfoxide (DMSO) were purchased from FS Chemicals
(Francfort, Germany) (analytical grade). RPMI 1640 was
purchased from Nacalai Tesque (Kyoto, Japan). Fetal
bovine serum, trypsin, streptomycin and penicillin were
obtained from PAA Laboratories GmBH (Pasching,
Austria). 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetra-
zolium bromide (MTT), propidium iodide and RNAse
A were purchased from Sigma (St. Loius, USA). Tissue
culture flasks, 6-well plates and 96-well plates were
obtained from TPP (Trasadingan, Switzerland). Annexin-V
FITC Kit was obtained from eBioscience Inc. (San
Diego, USA). Real Genomics Total RNA extraction kit
(RBC Biosciences, Taiwan) and GenomeLab GeXP Start
Kit (Beckman Coulter, USA) were also procured.
Cell culture
The human adenocarcinoma breast cancer cell line,
MCF-7, and mouse fibroblast cell line, 3T3 were
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(Rockville, USA). Cells were cultured in RPMI 1640
supplemented with 10% fetal bovine serum and 1%
penicillin and streptomycin, and maintained in humidified
incubator at 37°C in atmosphere of 5% CO2.
Preparation of EADs
The root powder of D. suffruticosa was supplied by
Primer Herber Sdn. Bhd. (Malaysia). The plant with
voucher specimen number SK1937/11 was deposited in
the herbarium of Institute of Bioscience, Universiti Putra
Malaysia. Briefly, 100 g of the powder was soaked in
300 mL of hexane at a ratio of 1:3 (w/v) with occasional
shaking using a rotary shaker for three times at 3:1:1 day
interval. The mixture solvent was collected and filtered
using Whatman No. 1 filter paper. The residue was dried
in an oven at 40°C and subsequently used for successive
extraction of dichloromethane followed by ethyl acetate
using the same methods. Lastly, filtered ethyl acetate
extract was evaporated using a vacuum rotary evapo-
rator (Buchi, Switzerland) [37]. The yield was weighed
and kept at -20°C until required. For subsequent expe-
riment, the stock of EADs in DMSO (30 mg/mL) was
used. The final concentration of DMSO was 0.33% in
all the extracts prepared. DMSO at 0.33% is non-
toxic to the cell line mentioned above [38].
Cytotoxicity of EADs
Cytotoxicity of EADs on MCF-7 cells was determined by
the MTT (3-(4,5-dimethylthiazol-2-Yl)-2,5-diphenyltetrazo-
lium bromide) assay [39]. Briefly, 1x105 of cells were seeded
in each well of a 96-well plate. After 24 hours incubation,
cells were treated with EADs (3.13 to 100 μg/mL).
Untreated control cells were also included. After incubation
with EADs for 24, 48 and 72 hours, 20 μL of 5 mg/mL of
MTT was added into each well and incubated for
3 hours. Active mitochondria in live cells reduced
MTT to crystalline purple blue formazan. The number of
living cells was proportionate to the amount of crystalline
purple blue formazan produced. After incubation, media in
each well was discarded and 100 μL of DMSO was added
to solubilize the purple blue formazan. The absorbance was
measured with an ELISA plate reader (Biotek, USA) at
wavelength of 570 nm, and 630 nm as background. A graph
of percentage of cell viability versus concentration of EADs
was plotted and the IC50 (concentration that inhibits 50%
of cell growth compared to control) was determined.
Cell morphology study of apoptosis by inverted light
microscope
Briefly, 3 × 105 of MCF-7 cells were seeded in each well
of a 6-well plate. After 24 hours of incubation, cells were
treated with EADs at concentration of 25 and 50 μg/mL.
Control untreated cells were also included. Morphologicalchanges of cells untreated and treated with EADs were
examined under an inverted light microscope (Olympus,
Tokyo, Japan) after 24, 48 and 72 hours. The cells were
captured at the same spot at different time interval.
Cell cycle analysis
Briefly, 3 × 105 of MCF-7 cells were seeded in each
well of a 6-well plate and treated with EADs at 25 and
50 μg/mL. Control untreated cells were also included. After
incubation for 24, 48 and 72 hours, cells were trypsinized
and washed with PBS. After centrifugation, cell suspension
was resuspended repeatedly into single cells prior fixation
with 70% ethanol. Fixed cells were kept at -20°C for at least
2 hours. Later, fixed cells were washed with PBS twice
and the supernatant was discarded. Cell pellets were
resuspended with 425 μL of PBS in a round bottom
tube. Next, 50 μL of RNAse and 25 μL of propidium
iodide were added into the cell suspension and incubated
for 15 minutes on ice in the dark. FACS Calibur (BD
Biosciences, USA) and Cell Quest Pro software (BD
Biosciences, USA) was used to determine the cell cycle
distribution. A total of 10,000 of cells were acquired each
time using FACS Calibur flowcytometer. Flowcytometric
data were analyzed using Modfit software and displayed in
histogram cell count (у-axis) against DNA content (x-axis).
Annexin V/PI apoptosis assay
Briefly, 3 × 105 of MCF-7 cells were seeded in each
well of a 6-well plate and treated with EADs at 25 and
50 μg/mL. Control untreated cells were also included. After
incubation for 24, 48 and 72 hours, cells were trypsinized,
washed twice with PBS and the supernatant was discarded.
The cell pellets were mixed with 185 μL of 1X binding
buffer. Next, 5 μL of Annexin-V FITC and 10 μL of
propidium iodide (PI) were added into the suspension
and incubated at room temperature for 10 minutes in the
dark. Subsequently, 300 μL of 1X binding buffer was added
prior to measurement using FACS calibur flowcytometer
and Cell Quest Pro software (BD Biosciences, USA).
Samples were kept on ice. This assay was carried out
following manufacturer’s kit from BenderMedsystem
(Vienna, Austria). The fluorescence colour was detected
through 530 and 585 nm band pass filter. A total of 10,000
cells were acquired. Flowcytometric data were analyzed
using FlowJo 7.6 software and displayed in dot plot of
Annexin V/FITC (y-axis) against PI (x-axis).
Multiplex mRNA expression analysis using GeXP analysis
system
RNA isolation
Briefly, 3 × 105 of MCF-7 cells were seeded in each well
of a 6-well plate and treated with EADs at 25 and 50 μg/
mL. Untreated control cells were also included. Untreated
and EADs treated cells were trypsinized and washed twice
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Genomics Total RNA extraction kit (RBC Biosciences,
Taiwan).
Reverse transcription and polymerase chain reaction
Samples were prepared according to the GenomeLab
GeXP Start Kit (Beckman Coulter, USA). Briefly, 2 μL of
customized reverse primers of the desired genes were
mixed with 11 μL of RNA free water, 4 μL of reverse
transcription buffer, 1 μL of reverse transcriptase and
1 μL of 50 ng/μL of sample. The reverse transcription
reaction was run for 1 minute at 48°C, 60 minutes at 42°C
and 5 minutes at 95°C. Subsequently, the cDNA produced
was amplified by PCR reaction. Next, 4 μL of 5X
PCR buffer, 4 μL of magnesium chloride, 2 μL of
customized forward primers mixture (Table 1), 0.7 μL of
Taq polymerase and 9.3 μL of cDNA were mixed and run
at specified time and temperature.
GeXP multiplex analysis
The GenomeLab GeXP genetic analysis system (Beckman
Coulter, USA) was used to examine the expression
level of genes involved in apoptosis pathway. The forward
and reverse primers were supplied by First Base Ltd.
(Selangor, Malaysia). The genes and their primer sequences
were listed in Table 1. Briefly, 1 μL of PCR product was
mixed with 38.5 μL of sample loading solution and 0.5 μL
of DNA size standard, and added into sample plate to start
the sample run using GeXP Genetic Analysis System
(Beckman Coulter, USA). The amplified fragments were
separated according to their respective size by capillary gel
electrophoresis in the GeXP system. Results were analyzed
using the Fragment Analysis module of the GeXP system
software and eXpress Profiller software. The normalization
was performed using beta actin.
Statistical analysis
Data were represented as mean ± SD of at least three
independent experiments. Data were analyzed usingTable 1 List of genes with the primer and product size






Beta actin NM_01101 230 GATCATTGCTCCTCCTGAGC
SOD1 NM_000454 320 TGGGGACAATACACAAGG
SOD2 NM_000636 330 AAAGGAGAGTTGCTGGAG
Akt1 NM_001014431 197 GAGGAGATGGACTTCCGGTC
NF-κB NM_001077493 204 GCGGGCGTCTAAAATTCTG
p53 NM_001126117 168 GGGGAGCAGGGCTCA
p38 MAPK NM_001315 247 TTCAGTCTTTGACTCAGATGCC
Catalase NM_001752 350 GGCAGCTATGTGAGAGCC
Forward universal primer sequence (AGGTGACACTATAGAATA).IBM SPSS version 20. Statistical test one way ANOVA
and Tukey post hoc test were conducted for pairwise
comparisons. P value less than 0.05 was considered
statistically significant.
Results
Cytotoxic properties of EADs on MCF-7 cells
As shown in Figure 1, significant cytotoxic effect of
EADs in MCF-7 cells was noted at 25, 50 and 100 μg/mL
compared to the control at various time points (P < 0.05).
The cytotoxic effect was time-and dose-dependent.
Treatment with EADs at 25 and 50 μg/mL reduced
the cell viability from 86.3% to 29.6% and 85.5% to
18.3%, respectively, from 48 to 72 hours (P < 0.05). IC50
values of EADs were 76 ± 2.3, 58 ± 0.7 and 39 ± 3.6 μg/mL,
respectively, at 24, 48 and 72 hours. Based on the cytotoxic
effect, 25 and 50 μg/mL of EADs, and incubation time of
24 and 48 hours were selected for further analysis.
Morphological changes of MCF-7 cells following
treatment with EADs
The cell number reduced at 50 μg/mL of EADs at
72 hours. Cell detachment, cell rounding, cytoplasmic
condensation and cell shrinkage were observed at 48
and 72 hours in MCF-7 cells treated with 50 μg/mL of
EADs (Figure 2). At 25 μg/mL of EADs, cell shrinkage
and cytoplasmic condensation were noted but the cell
number increased over time.
EADs induced cell cycle arrest in MCF-7 cells
The cell cycle phase distribution of MCF-7 cells
treated with EADs at 24 and 48 hours is depicted in
Figure 3. The cell cycle arrest by EADs was time- and
concentration-dependent. At 24 and 48 hours, an increase
in cell population in G1 at 25 μg/mL of EADs was noted
(P < 0.05). On the other hand, 50 μg/mL of EADs at
24 hours elevated the number of cells in S and G2/M
compared to control, accompanied by a decline in G1
phase cell population (P < 0.05). Meanwhile, at 48 hours,
G2/M phase cell population was ascended compared to
the control following treatment with 50 μg/mL of EADs
(P < 0.05). Increase in the population of cells at sub-G1
phase was observed following treatment with EADs
(P < 0.05).
EADs induced apoptosis in MCF-7 cells
Induction of apoptosis by EADs was quantitatively
determined by Annexin V-FITC and propidium iodide
fluorescence staining. The percentage of early apoptotic
cells increased in a dose and time dependent manner
(Figure 4). At 24 hours, the early apoptotic cells increased
from 16.7% at 25 μg/mL to 42.7% at 50 μg/mL of EADs
compared to 8.3% in the control. The number of late
apoptotic cells increased from 9.9% to 18.3% in 50 μg/ml
Figure 1 Effect of EADs on the viability of MCF-7 cells as determined by MTT assay. Cytotoxic effect of EADs was investigated on (a) breast
adenocarcinoma cell line, MCF-7 and (b) non-neoplastic mouse fibroblast cell line, 3 T3. The result indicated that EADs was relatively non-selective
towards cancerous cell line. Antiproliferative effect of EADs was compared to reference drug, tamoxifen on MCF-7 cell line (Figure 1c). Data are
represented as mean percentage of viable cells in bars ± SD of at least three replicates in three independent tests. An asterisk * indicates statistically
significant different from untreated control (P < 0.05).
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apoptotic cells increased to 36.1% at 25 μg/mL of EADs,
and elevated to 45.5% at 50 μg/mL of EADs.EADs altered the expression of oxidative stress pathway
related genes
The MCF-7 cells treated with 25 and 50 μg/mL of EADs
significantly upregulated the expression level of SOD1,
SOD2, p53, p38 MAPK, catalase and NF-κB genes but
downregulated Akt1 (P < 0.05) compared to the control
(Figure 5).Discussion
Cancer cells evolve to avoid apoptosis-inducing signaling
pathway in order to survive [40]. Thus, induction of apop-
tosis in cancer cells can be a promising treatment method
in cancer therapy. Natural-derived products, regardless of
crude extracts or isolated active compounds, had drawn
growing attention as agent in cancer therapy, due to their
ability to modulate apoptosis [41-43].
In this study, EADs has been shown to be cytotoxic
and inhibit the proliferation of MCF-7 cells in a time- and
dose-dependent manner. The cytotoxic property may be
due to the presence of phytochemicals such as saponins,
triterpenes, tannins and polyphenolic compounds in the
extract [37]. Man et al. [44] reported that saponins
exhibited anti-tumorigenic effects via multiple anticancer
pathways because of the great diversity of their structures.
For instance, a steroidal saponin known as Dioscin
was described to inhibit tumor through induction of
oxidative stress [45]. In addition, triterpenes from
Antrodia camphorata were found to exhibit cytotoxic
effect towards HT-29 human colon cancer cells [46].
Polyphenolic compounds exist in plants are associated
with anticancer activity by interaction with key enzymesin cellular signaling pathways, cell cycle, apoptosis and
metastasis [47,48].
The treatment of EADs elicited non-phase specific cell
cycle arrest in MCF-7 cells. For instance, at 25 μg/mL of
EADs, cell cycle arrest at G1 at 48 hours was noted. On
the other hand, at 50 μg/mL of EADs, the cell cycle
arrest was at S and G2M at 24 hours, but G2M cell cycle
arrest at 48 hours. The cell cycle phase non-specific
nature of EADs denotes that it kills tumor cells in either
resting or dividing state. The non-specific phase drugs
are among the most effective drugs against slow-growing
tumors [49]. Ozawa et al. [50] demonstrated that the
action of a non-phase specific antitumor agent is basically
dependent on the concentration and time. This finding is
in accordance with the cytotoxicity of EADs.
MCF-7 cells treated with EADs exhibited certain apop-
totic features such as cell rounding, cell shrinkage and
cytoplasmic condensation, and also the presence of sub-G1
phase population. The induction of apoptosis was then
further confirmed by flowcytometric Annexin V-FITC/PI.
One of the hallmarks of apoptosis is the externalization of
phospholipid phosphatidylserine (PS) by translocation
from the inner to outer layer of plasma membrane for
recognition of phagocytes during early stage of apoptosis
[51]. Hence, phosphatidylserine can serve as specific
target for the detection of early apoptotic cells. Annexin
V-FITC which has high binding affinity for phosphati-
dylserine is appropriate conjugate for identification of
early stage apoptosis [52,53]. Simultaneously, propi-
dium iodide is included for dye exclusion to differen-
tiate between apoptotic and necrotic cells [54].
Interestingly, other prominent characteristics of apop-
tosis such as membrane blebbing, DNA fragmentation and
formation of apoptotic bodies were absent. MCF-7 cells
are previously reported lack in caspase-3, an important
component in the cascade of apoptosis, due to deletion of
Figure 2 (See legend on next page.)
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Figure 2 Morphological changes of MCF-7 cells treated with EADs observed under an inverted light microscope. The cells
exhibited morphological changes and characteristics of apoptosis such as cell shrinkage and rounding (black arrow), and detachment
from the substatum (white arrow). Decrease in cell population was noted with the increase in the concentration of the extract. (a) 100X magnification
(b) 400X magnification
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caspase-3 deficient MCF-7 cells do not display some
typical morphological characteristics of apoptosis such
as chromatin condensation, DNA fragmentation and
membrane blebbing [56]. During normal condition in
apoptosis, caspase-3 is activated and responsible for
morphological and biochemical changes related to the
apoptosis execution [57]. It is speculated that other caspases
such as caspase-6 or caspase-7 or caspase-independent
pathway are involved in apoptosis induced by EADs [58].
Many anticancer agents induced apoptotic cell death
by introducing oxidative stress to a threshold that
compromises cell viability, disturbing the equilibrium
between ROS and antioxidants within cancer cells
[59]. From the GeXP analysis data, the expression of
SOD1, SOD2, and catalase genes was upregulated. It
is postulated that the antioxidant defense system inFigure 3 Cell cycle analysis of MCF-7 breast cancer cells treated with
distribution in MCF-7 cells were analysed using flowcytometry analysis. Bar
treated with EADS for (a) 24 hours and (b) 48 hours. DNA histogram (Figure
cells at 24 and 48 hours. The data are presented as mean ± standard deviation
statistically significant different from untreated control (P < 0.05).MCF-7 cells is triggered in response to increase cellular
oxidative stress generated by EADs. Superoxide dismutases
(SODs) act as the sole enzyme that dismutates superoxide
radicals (O2
- ) into hydrogen peroxide (H2O2) and oxy-
gen (O2). SOD1 is mainly located in the cytosol and
intermembrane space of mitochondria while SOD2 is
present in the matrix of mitochondria [16]. The product
of SODs action, H2O2, is metabolized by an antioxi-
dant known as catalase into water and oxygen [60].
In this case, SOD1, SOD2 and catalase were upregu-
lated in order to scavenge the elevating level of ROS
induced by EADs. Nonetheless, in spite of the protective
mechanism of the antioxidants, MCF-7 cells still
underwent apoptosis. Hence, it is believed that the
ROS level induced by EADs was high and has surpassed
the antioxidant capacity, leading to apoptosis in MCF-7
cells [59,61].EADs at 24 and 48 hours. Effects of EADs on the cell cycle
charts representing the percentage of cell populations in MCF-7 cells
3c) displayed cell cycle phase distribution of control and EADs-treated
of three replicates in three independent tests. An asterisk * indicates
Figure 4 Induction of apoptosis in MCF-7 cells by EADs determined using Annexin V-PI flowcytometry technique. The data representing
three independent tests which displayed similar results. The lower left quadrant represents intact viable cells (Annexin-FITC and PI negative). The lower
right quadrant represents early apoptotic cells (Annexin-FITC positive and PI negative). The upper right region represents late apoptotic cells or secondary
necrotic cells (Annexin-FITC and PI positive). The data are presented as dot plots of Annevin V/FITC against PI of at least three independent tests.
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in a concentration-dependent manner suggesting the
involvement of Akt pathway in EADs-induced apoptosis.
Previous studies have shown that apoptosis in MCF-7 cells
was related to the inhibition of Akt signaling pathwayafter treatment with Wogonin or retinoic-acid [62,63].
Generally, Akt is a serine-threonine kinase that facilitates
the control of balance between survival and apoptosis.
Oxidative stress has been associated with the regulation
of Akt pathway [64,65]. Studies have reported that in
Figure 5 Expression level of genes involved in oxidative
stress-induced apoptotic pathway following treatment with
EADs using GeXP analysis system. The data are presented as
mean ± standard deviation of three replicates in at least three
independent tests. An asterisk * indicates statistically significant
different from untreated control (P < 0.05).
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it is important in apoptosis process [66]. Akt signalling
pathway deregulation in cancer cells has been one of the
targets in the search of potential cancer treatment [67].
In this study, upregulation of p53 level was noted,
which is possibly related to oxidative stress. Other than
antioxidant defense, cells counterbalance the effect of
oxidative stress by activation of p53-dependent pathways.
p53 is a nuclear transcription factor that can be activated
in response to oxidative stress to promote apoptosis by
regulation of multitude of downstream effectors. Once it
is activated, cell cycle is arrested for DNA repair processto restore normal cell function [68]. We propose that
EADs-induced oxidative stress will increase the p53 level
and subsequently lead to the non-phase specific cell cycle
arrest in MCF-7 cells. However, if cells are not able to
overcome the oxidative stress damage and DNA damage
cannot be repaired, p53 becomes a mediator to induce
apoptosis [68,69].
EADs treatment in MCF-7 cells was also found to
upregulate NF-κB expression. It is believed that increased
activity of NF-κB in EADs-induced apoptosis is again due
to oxidative stress. The nuclear transcription factor NF-κB
regulates genes involved in a number of biological
processes such as inflammation, cell survival, cell
differentiation and cell growth [70]. NF-κB enhances the
pro-inflammatory and anti-apoptotic genes expression,
and acts as a protective barrier for cells against oxidative
stress. However, NF-κB has also been associated with
apoptosis and brings to activation of certain apoptosis-
related genes [58]. Furthermore, many studies supported
the pro-apoptotic effect exerted by NF-κB in response
to oxidative stress [71]. It has been concluded that
pro-apoptotic or anti-apoptotic effect of NF-κB depends
on stimuli received, signaling pathway interactions,
transcriptional regulation and function of genes it
modulates [72]. ROS activate NF-κB via the dissociation
of IκB from NF-κB through phosphorylation, thereby
enable NF-κB to enter nucleus and activate transcription
by binding to DNA [73].
Another intracellular signaling molecule that is involved
in regulation of oxidative stress is p38 MAPK which
belongs to MAPK superfamily. In accordance, a marked
increase in gene expression of p38 MAPK in MCF-7 cells
treated with EADs was observed. The p38 MAPK strongly
responds to stress-inducing signals such as oxidative stress
and cause apoptosis as a result of cellular injuries [16].
The p38 MAPK plays a role in regulation of cellular
biological functions like inflammation, proliferation,
differentiation, survival. [74,75]. This pathway has been
known as tumor suppressor because it is often activated by
cellular stress and control signals that inhibit proliferation
or enhance apoptosis [76]. Investigation of ROS activated
p38 MAPK has been carried out widely. In addition, p38
MAPK and Akt pathways were found to be interconnected
in numerous cases. For example, a study reported
that suppression of Akt signaling pathway excites p38
MAPK related apoptosis and vice versa [77]. Our result
also indicated that oxidative stress stimulates downregula-
tion of Akt and facilitates upregulation of p38 MAPK,
hence give rise to apoptosis in EADs treated MCF-7 breast
cancer cells.
Nonetheless, several studies documented that Akt
pathway is involved in the activation of NF-κB pathway
under the treatment of TNF-α and growth factor [78].
However, it has also been demonstrated that NF-κB
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NF-κB binding and transcription activity can still be
activated despite of the inhibition of the Akt pathway
[79]. Hence, it is postulated that although some
crosstalks exist between Akt pathway and NF-κB
pathway in response to EADs-induced oxidative stress in
MCF-7 cells, but it appears that these two pathways can
act independently. As discussed above, in response to
oxidative stress, p53 is able to exert pro-apoptotic
effect. Furthermore, it has been shown that p38 MAPK
can phosphorylate p53, and play part in regulation of
p53 expression under stress situation by stabilizing
the p53 protein.Conclusions
In summary, EADs was found to exhibit cytotoxicity
towards MCF-7 cell line possibly via introduction of
oxidative stress that activates Akt, NF-κB, p53, and
p38 MAPK signaling pathway. It shows the potential
of EADs to be developed into an anticancer agent.
Nevertheless, the shift of attention towards bioactive
compound that are responsible for the anti-breast cancer
activity of EADs, and understanding of its mechanism of
action are utmost essential to discover the potential of the
extract in breast cancer intervention.
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